Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Rangering i aksjer #40612
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Aksjekurs
$0.13607016
Sist synkronisert: 2024-09-10
Markedsverdi
$112.29K
Endring (1 dag)
22.46%
Endring (1 år)
0.00%
Land
GB
Handel BiVictriX Therapeutics Plc (BVX)

Kategori

Utbytteavkastning for BiVictriX Therapeutics Plc (BVX)
BiVictriX Therapeutics Plc (aksjesymbol: BVX) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for BiVictriX Therapeutics Plc (BVX) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter